A detailed history of Mediolanum International Funds LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mediolanum International Funds LTD holds 5,299 shares of VRTX stock, worth $2.16 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,299
Previous 37,404 85.83%
Holding current value
$2.16 Million
Previous $16.5 Billion 85.16%
% of portfolio
0.03%
Previous 0.27%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$460.0 - $505.78 $14.8 Million - $16.2 Million
-32,105 Reduced 85.83%
5,299 $2.45 Billion
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $157,909 - $195,183
402 Added 1.09%
37,404 $16.5 Billion
Q1 2024

May 03, 2024

BUY
$407.69 - $446.08 $15.1 Million - $16.5 Million
37,002 New
37,002 $15.4 Billion

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Mediolanum International Funds LTD Portfolio

Follow Mediolanum International Funds LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mediolanum International Funds LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mediolanum International Funds LTD with notifications on news.